Prema Cognition is a digital healthtech company focused on earlier detection of dementia. It is the company behind PREMAZ, a digital cognitive assessment created in collaboration with the University of Cambridge Memory Lab. PREMAZ is designed to identify subtle changes in cognitive decline long before symptoms appear. By translating advanced neuroscience into a clinician-ready digital tool, Prema Cognition is enabling earlier intervention and supporting research into brain health. The platform is already in use across clinics and research settings in the UK and US. Prema Cognition was co-founded by medical doctor Dr. Julia Cooney, a Forbes 30 Under 30 honoree and Cameron Kirkpatrick.
Prema Cognition
- Health
- Cambridge, United Kingdom
- £550k
- premaz.org
- Update Information
More venture news
- 29 Jul 2026

MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026

DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth - 24 Jul 2026

TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
